[Sinphar] Announcement of the Company's Board Resolution to Lift Non-Compete Restrictions on Managers
Sinphar announced that it has approved the concurrent appointments of CFO Chen Chih-Hsiao and General Manager of Marketing Center Chen Chang-Lung at Sinphar Biotech Co., Ltd., lifting non-compete restrictions. This enhances management flexibility.
📋 Article Processing Timeline
- 📰 Published: May 5, 2026 at 09:00
- 🔍 Collected: May 6, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 6, 2026 at 08:51 (51 min after Collected)
1. Date of board resolution: 115/05/05
2. Names and titles of managers permitted to engage in competitive acts: CFO Chen Chih-Hsiao, General Manager of Marketing Center Chen Chang-Lung
3. Items of permitted competitive acts: Chen Chih-Hsiao serves as corporate director representative and concurrently chairman of Sinphar Biotech Co., Ltd.; Chen Chang-Lung serves as corporate director representative of Sinphar Biotech Co., Ltd.
4. Period of permitted competitive acts: During their tenure as managers of the Company
5. Resolution status (Please explain voting results according to Article 32 of the Company Act): Unanimously approved by all attending directors after inquiry by the chairman
6. If the permitted competitive acts involve operations in mainland China, names and titles of managers (if not related to mainland China operations, please enter "Not Applicable" below): Not Applicable
7. Name and position of the company in mainland China: Not Applicable
8. Address of the company in mainland China: Not Applicable
9. Business scope of the company in mainland China: Not Applicable
10. Degree of impact on the Company's financial business: None
11. If the manager has invested in the aforementioned mainland China enterprise, investment amount and shareholding ratio: Not Applicable
12. Other matters that should be specified: None
2. Names and titles of managers permitted to engage in competitive acts: CFO Chen Chih-Hsiao, General Manager of Marketing Center Chen Chang-Lung
3. Items of permitted competitive acts: Chen Chih-Hsiao serves as corporate director representative and concurrently chairman of Sinphar Biotech Co., Ltd.; Chen Chang-Lung serves as corporate director representative of Sinphar Biotech Co., Ltd.
4. Period of permitted competitive acts: During their tenure as managers of the Company
5. Resolution status (Please explain voting results according to Article 32 of the Company Act): Unanimously approved by all attending directors after inquiry by the chairman
6. If the permitted competitive acts involve operations in mainland China, names and titles of managers (if not related to mainland China operations, please enter "Not Applicable" below): Not Applicable
7. Name and position of the company in mainland China: Not Applicable
8. Address of the company in mainland China: Not Applicable
9. Business scope of the company in mainland China: Not Applicable
10. Degree of impact on the Company's financial business: None
11. If the manager has invested in the aforementioned mainland China enterprise, investment amount and shareholding ratio: Not Applicable
12. Other matters that should be specified: None